C3.ai(US:AI) Globenewswire·2025-10-16 20:00Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3]. Group 1: Allegations and Impact - The lawsuit claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth potential [3]. - The CEO's health issues significantly affected the company's ability to close deals, which management failed to address effectively [3]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to leadership reorganization and the CEO's health [3]. Group 2: Stock Price Reaction - Following the announcement of poor financial results, C3.ai's stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Group 3: Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates throughout the case lifecycle [4].